Atrial Fibrillation-Importance, recognition, and treatment
-
Register
- User - $15
Atrial fibrillation (AF) remains the most common heart arrhythmia in the general population and is associated with significant morbidity and mortality. Appropriate identification and treatment are critical to prevent potential devastating sort-and long-term outcomes. Practitioners in all areas of practice will encounter patients with various stages of AF, and therefore must be able to identify, classify and treat this common arrhythmia. This session will focus on the classification of AF, identification and various treatment and preventative options.
Credits: 1.50 contact hours; 0.75 are pharmacology
Expiration Date: December 31st, 2025
$15.00
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Discuss the growing incidence and importance of AF in the population.
-Discuss diagnostic criteria for AF
-Appraise the pharmacologic and nonpharmacologic options for AF management, including the use of anticoagulation for stroke prevention
Kristine Scordo PhD, RN, ACNP-BC, FAANP
Professor and Director
Wright State University
Dr. Kristine Scordo has over 35 years as an APRN including former founder and director of the acute care NP program in Dayton, OH. She has lectured extensively at international, national and regional conferences on topics in infectious diseases and adult cardiology, establishing a critical care fellowship in Hong Kong. She was involved in developing the competencies for graduate fellowships and continues to be a CCNE site visit accrediting colleges and fellowships. She and has been awarded multiple grant funding and has multiple publications and continues to practice at TriHealth in Cincinnati, Ohio.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 0.75 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Kristine Scordo, PhD, RN, ACNP-BC, FAANP have disclosed have disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
